La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Applied DNA Sciences a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Applied DNA Sciences..

Applied DNA Sciences (NASDAQ:APDN) Azioni, Catena delle Opzioni

Applied DNA Sciences

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

APDN

I futures sulle azioni statunitensi sono in rialzo e questi cinque titoli promettono di essere al centro dell&#39;attenzione degli investitori.

Pre-market: 5 titoli da monitorare oggi, 18 dicembre 2024

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences Inc

Press Releases

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Management

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Events

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Penny Stocks

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Comments

Applied DNA Sciences

Applied DNA Sciences (APDN) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO